Summary

The global Beraprost Sodium market size is predicted to grow from US$ 120 million in 2025 to US$ 136 million in 2031; it is expected to grow at a CAGR of 2.2% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.
The Beraprost Sodium market is driven by the rising prevalence of peripheral arterial disease (PAD) and the growing demand for effective treatment options. Beraprost Sodium is a prostacyclin analog used to improve blood flow and manage symptoms in patients with PAD, a condition characterized by reduced blood flow to the extremities. The increase in risk factors such as diabetes, smoking, and obesity contributes to market growth. The development of oral formulations of Beraprost Sodium has improved patient convenience and adherence to treatment. However, the market also faces challenges, including the need for long-term treatment and the potential for side effects in some patients. Additionally, cost considerations and reimbursement issues can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer innovative and cost-effective Beraprost Sodium formulations, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective PAD treatment options.
LP Information, Inc. (LPI) ' newest research report, the “Beraprost Sodium Industry Forecast” looks at past sales and reviews total world Beraprost Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Beraprost Sodium sales for 2025 through 2031. With Beraprost Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beraprost Sodium industry.
This Insight Report provides a comprehensive analysis of the global Beraprost Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beraprost Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beraprost Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beraprost Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beraprost Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Beraprost Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Sustained Release Tablets
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Toray
Taide Pharma
Nichiiko
Daiichi Sankyo Co Ltd
Nihon Generic Co Ltd
Yoshindo
NABIQASIM INDUSTRIES
Shin Poong Pharmaceutical
Ohara Inc
Kyorin Holding
KYOUSOUMIRAI PHARM
Teva
Alfresa Pharma
Lupin Laboratories
Astellas Pharma
Sawai Pharmaceutical
Viatris
Kaken Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Beraprost Sodium market?
What factors are driving Beraprost Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beraprost Sodium market opportunities vary by end market size?
How does Beraprost Sodium break out by Type, by Application?

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Beraprost Sodium Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Beraprost Sodium by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Beraprost Sodium by Country/Region, 2020, 2024 & 2031
2.2 Beraprost Sodium Segment by Type
2.2.1 Tablet
2.2.2 Sustained Release Tablets
2.3 Beraprost Sodium Sales by Type
2.3.1 Global Beraprost Sodium Sales Market Share by Type (2020-2025)
2.3.2 Global Beraprost Sodium Revenue and Market Share by Type (2020-2025)
2.3.3 Global Beraprost Sodium Sale Price by Type (2020-2025)
2.4 Beraprost Sodium Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Beraprost Sodium Sales by Application
2.5.1 Global Beraprost Sodium Sale Market Share by Application (2020-2025)
2.5.2 Global Beraprost Sodium Revenue and Market Share by Application (2020-2025)
2.5.3 Global Beraprost Sodium Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Beraprost Sodium Breakdown Data by Company
3.1.1 Global Beraprost Sodium Annual Sales by Company (2020-2025)
3.1.2 Global Beraprost Sodium Sales Market Share by Company (2020-2025)
3.2 Global Beraprost Sodium Annual Revenue by Company (2020-2025)
3.2.1 Global Beraprost Sodium Revenue by Company (2020-2025)
3.2.2 Global Beraprost Sodium Revenue Market Share by Company (2020-2025)
3.3 Global Beraprost Sodium Sale Price by Company
3.4 Key Manufacturers Beraprost Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beraprost Sodium Product Location Distribution
3.4.2 Players Beraprost Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Beraprost Sodium by Geographic Region
4.1 World Historic Beraprost Sodium Market Size by Geographic Region (2020-2025)
4.1.1 Global Beraprost Sodium Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Beraprost Sodium Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Beraprost Sodium Market Size by Country/Region (2020-2025)
4.2.1 Global Beraprost Sodium Annual Sales by Country/Region (2020-2025)
4.2.2 Global Beraprost Sodium Annual Revenue by Country/Region (2020-2025)
4.3 Americas Beraprost Sodium Sales Growth
4.4 APAC Beraprost Sodium Sales Growth
4.5 Europe Beraprost Sodium Sales Growth
4.6 Middle East & Africa Beraprost Sodium Sales Growth
5 Americas
5.1 Americas Beraprost Sodium Sales by Country
5.1.1 Americas Beraprost Sodium Sales by Country (2020-2025)
5.1.2 Americas Beraprost Sodium Revenue by Country (2020-2025)
5.2 Americas Beraprost Sodium Sales by Type (2020-2025)
5.3 Americas Beraprost Sodium Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beraprost Sodium Sales by Region
6.1.1 APAC Beraprost Sodium Sales by Region (2020-2025)
6.1.2 APAC Beraprost Sodium Revenue by Region (2020-2025)
6.2 APAC Beraprost Sodium Sales by Type (2020-2025)
6.3 APAC Beraprost Sodium Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Beraprost Sodium by Country
7.1.1 Europe Beraprost Sodium Sales by Country (2020-2025)
7.1.2 Europe Beraprost Sodium Revenue by Country (2020-2025)
7.2 Europe Beraprost Sodium Sales by Type (2020-2025)
7.3 Europe Beraprost Sodium Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Beraprost Sodium by Country
8.1.1 Middle East & Africa Beraprost Sodium Sales by Country (2020-2025)
8.1.2 Middle East & Africa Beraprost Sodium Revenue by Country (2020-2025)
8.2 Middle East & Africa Beraprost Sodium Sales by Type (2020-2025)
8.3 Middle East & Africa Beraprost Sodium Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beraprost Sodium
10.3 Manufacturing Process Analysis of Beraprost Sodium
10.4 Industry Chain Structure of Beraprost Sodium
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beraprost Sodium Distributors
11.3 Beraprost Sodium Customer
12 World Forecast Review for Beraprost Sodium by Geographic Region
12.1 Global Beraprost Sodium Market Size Forecast by Region
12.1.1 Global Beraprost Sodium Forecast by Region (2026-2031)
12.1.2 Global Beraprost Sodium Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Beraprost Sodium Forecast by Type (2026-2031)
12.7 Global Beraprost Sodium Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Toray
13.1.1 Toray Company Information
13.1.2 Toray Beraprost Sodium Product Portfolios and Specifications
13.1.3 Toray Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Toray Main Business Overview
13.1.5 Toray Latest Developments
13.2 Taide Pharma
13.2.1 Taide Pharma Company Information
13.2.2 Taide Pharma Beraprost Sodium Product Portfolios and Specifications
13.2.3 Taide Pharma Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Taide Pharma Main Business Overview
13.2.5 Taide Pharma Latest Developments
13.3 Nichiiko
13.3.1 Nichiiko Company Information
13.3.2 Nichiiko Beraprost Sodium Product Portfolios and Specifications
13.3.3 Nichiiko Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Nichiiko Main Business Overview
13.3.5 Nichiiko Latest Developments
13.4 Daiichi Sankyo Co Ltd
13.4.1 Daiichi Sankyo Co Ltd Company Information
13.4.2 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolios and Specifications
13.4.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Daiichi Sankyo Co Ltd Main Business Overview
13.4.5 Daiichi Sankyo Co Ltd Latest Developments
13.5 Nihon Generic Co Ltd
13.5.1 Nihon Generic Co Ltd Company Information
13.5.2 Nihon Generic Co Ltd Beraprost Sodium Product Portfolios and Specifications
13.5.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Nihon Generic Co Ltd Main Business Overview
13.5.5 Nihon Generic Co Ltd Latest Developments
13.6 Yoshindo
13.6.1 Yoshindo Company Information
13.6.2 Yoshindo Beraprost Sodium Product Portfolios and Specifications
13.6.3 Yoshindo Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Yoshindo Main Business Overview
13.6.5 Yoshindo Latest Developments
13.7 NABIQASIM INDUSTRIES
13.7.1 NABIQASIM INDUSTRIES Company Information
13.7.2 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolios and Specifications
13.7.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 NABIQASIM INDUSTRIES Main Business Overview
13.7.5 NABIQASIM INDUSTRIES Latest Developments
13.8 Shin Poong Pharmaceutical
13.8.1 Shin Poong Pharmaceutical Company Information
13.8.2 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolios and Specifications
13.8.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shin Poong Pharmaceutical Main Business Overview
13.8.5 Shin Poong Pharmaceutical Latest Developments
13.9 Ohara Inc
13.9.1 Ohara Inc Company Information
13.9.2 Ohara Inc Beraprost Sodium Product Portfolios and Specifications
13.9.3 Ohara Inc Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ohara Inc Main Business Overview
13.9.5 Ohara Inc Latest Developments
13.10 Kyorin Holding
13.10.1 Kyorin Holding Company Information
13.10.2 Kyorin Holding Beraprost Sodium Product Portfolios and Specifications
13.10.3 Kyorin Holding Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kyorin Holding Main Business Overview
13.10.5 Kyorin Holding Latest Developments
13.11 KYOUSOUMIRAI PHARM
13.11.1 KYOUSOUMIRAI PHARM Company Information
13.11.2 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolios and Specifications
13.11.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 KYOUSOUMIRAI PHARM Main Business Overview
13.11.5 KYOUSOUMIRAI PHARM Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Beraprost Sodium Product Portfolios and Specifications
13.12.3 Teva Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 Alfresa Pharma
13.13.1 Alfresa Pharma Company Information
13.13.2 Alfresa Pharma Beraprost Sodium Product Portfolios and Specifications
13.13.3 Alfresa Pharma Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Alfresa Pharma Main Business Overview
13.13.5 Alfresa Pharma Latest Developments
13.14 Lupin Laboratories
13.14.1 Lupin Laboratories Company Information
13.14.2 Lupin Laboratories Beraprost Sodium Product Portfolios and Specifications
13.14.3 Lupin Laboratories Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Lupin Laboratories Main Business Overview
13.14.5 Lupin Laboratories Latest Developments
13.15 Astellas Pharma
13.15.1 Astellas Pharma Company Information
13.15.2 Astellas Pharma Beraprost Sodium Product Portfolios and Specifications
13.15.3 Astellas Pharma Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Astellas Pharma Main Business Overview
13.15.5 Astellas Pharma Latest Developments
13.16 Sawai Pharmaceutical
13.16.1 Sawai Pharmaceutical Company Information
13.16.2 Sawai Pharmaceutical Beraprost Sodium Product Portfolios and Specifications
13.16.3 Sawai Pharmaceutical Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Sawai Pharmaceutical Main Business Overview
13.16.5 Sawai Pharmaceutical Latest Developments
13.17 Viatris
13.17.1 Viatris Company Information
13.17.2 Viatris Beraprost Sodium Product Portfolios and Specifications
13.17.3 Viatris Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Viatris Main Business Overview
13.17.5 Viatris Latest Developments
13.18 Kaken Pharmaceutical
13.18.1 Kaken Pharmaceutical Company Information
13.18.2 Kaken Pharmaceutical Beraprost Sodium Product Portfolios and Specifications
13.18.3 Kaken Pharmaceutical Beraprost Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Kaken Pharmaceutical Main Business Overview
13.18.5 Kaken Pharmaceutical Latest Developments
14 Research Findings and Conclusion